InMode (INMD) Cash from Investing Activities (2018 - 2026)
InMode's (INMD) quarterly Cash from Investing Activities came in at $37.7 million in Q2 2026, down 47.41% year-over-year from $71.7 million in Q2 2025, and down 65.46% quarter-over-quarter from $109.1 million in Q1 2026.
Analysis
InMode (INMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends
InMode has disclosed Cash from Investing Activities across 9 years of filings, most recently posting $37.7 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 47.41% year-over-year to $37.7 million; the TTM figure through Jun 2026 stood at $185.7 million (down 45.23% YoY), while the FY2025 annual figure was $186.0 million, up 14.69% from the prior year.
- Cash from Investing Activities came in at $37.7 million for Q2 2026 at InMode, down from $109.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $114.1 million in Q3 2024 to a low of -$69.8 million in Q3 2023.
- Average Cash from Investing Activities over 5 years is $13.9 million, with a median of $12.3 million recorded in 2023.
- The largest YoY upside for Cash from Investing Activities was 647.89% in 2023 against a maximum downside of 117.11% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$38.3 million in 2022, then sank by 34.79% to -$51.6 million in 2023, then surged by 250.84% to $77.8 million in 2024, then slumped by 65.02% to $27.2 million in 2025, then jumped by 38.43% to $37.7 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $37.7 million in Q2 2026, $109.1 million in Q1 2026, and $27.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -108.50 Mn |
| 10 | InMode | 944.68 Mn | 462.56 Mn | 71.52 Mn | 37.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.68 Mn |
| Mar 31, 2026 | 109.10 Mn |
| Dec 31, 2025 | 27.22 Mn |
| Sep 30, 2025 | 11.67 Mn |
| Jun 30, 2025 | 71.66 Mn |
| Mar 31, 2025 | 75.49 Mn |
| Dec 31, 2024 | 77.82 Mn |
| Sep 30, 2024 | 114.06 Mn |
| Jun 30, 2024 | 17.73 Mn |
| Mar 31, 2024 | -47.39 Mn |
| Dec 31, 2023 | -51.59 Mn |
| Sep 30, 2023 | -69.82 Mn |
| Jun 30, 2023 | 13.01 Mn |
| Mar 31, 2023 | -27.56 Mn |
| Dec 31, 2022 | -38.28 Mn |
| Sep 30, 2022 | -56.13 Mn |
| Jun 30, 2022 | -2.37 Mn |
| Mar 31, 2022 | -12.69 Mn |
| Dec 31, 2021 | -30.81 Mn |
| Sep 30, 2021 | -48.14 Mn |